| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.88B | +82.6% |
| R&D Expense | $2.80B | +36.2% |
| SG&A Expense | $3.14B | +35.4% |
| Operating Income | -$1.83B | +52.2% |
| Interest Expense | $565.0M | +17.0% |
| Pre-tax Income | -$9.43B | -819.6% |
| Income Tax | -$181.0M | +63.2% |
| Net Income | -$9.14B | -1742.9% |
| EPS (Basic) | -$4.64 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.21B | -2.0% |
| Short-term Investments | $103.0M | — |
| Accounts Receivable | $2.78B | +13.9% |
| Current Assets | $9.25B | +4.9% |
| Total Assets | $32.11B | -17.2% |
| Current Liabilities | $8.85B | -1.9% |
| Long-term Debt | $9.36B | -0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $642.0M | +244.3% |
| Capital Expenditures | $252.0M | -15.4% |
| Investing Cash Flow | -$1.64B | -36.3% |
| Financing Cash Flow | $15.0M | -99.2% |
| Free Cash Flow | $390.0M | +152.5% |
| -1684.6% |
| EPS (Diluted) | -$4.65 | -1503.4% |
| Total Liabilities |
| $23.61B |
| +0.8% |
| Stockholders' Equity | $7.34B | -49.2% |